Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,497 public trials 2,844 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

NCT03376672

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Helsinki University Central Hospital Helsinki, Finland
  • Central Finland Central Hospital Jyväskylä, Finland
  • Kainuu Central Hospital Kajaani, Finland
  • Kymenlaakso Central Hospital Kotka, Finland
View all 26 locations
View Trial Details
Active, not recruiting

EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)

NCT05444894

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +10 more
Locations
  • University of California San Francisco Oakland, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Columbia University Medical Center - Department of Pediatrics New York, United States
  • Columbia University Medical Center New York, United States
View Trial Details
Active, not recruiting

MIF Involvement in AML

NCT03918655

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Laboratoire d'hématologie Hôpital Saint Antoine Paris, France
View Trial Details
Active, not recruiting

Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability

NCT03333187

Conditions
Bone Marrow Diseases, Bone Marrow Fibrosis, Hematologic Diseases, +3 more
Locations
  • Universitätsklinkum Aachen Aachen, Germany
  • HELIOS Klinikum Berlin-Buch Berlin, Germany
  • Universitätsklinikum Bonn Bonn, Germany
  • Universitätsklinikum Düsseldorf Düsseldorf, Germany
View all 14 locations
View Trial Details
Active, not recruiting

Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone

NCT04392037

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • NWZ Alkmaar, Netherlands
  • Amsterdam UMC, location AMC Amsterdam, Netherlands
  • Amsterdam UMC, location VUmc Amsterdam, Netherlands
  • Rijnstate Arnhem, Netherlands
View Trial Details
Active, not recruiting

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia

NCT05883956

Conditions
Behavior, Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Pindara Private Hospital Benowa, Queensland, Australia
  • Townsville Hospital Townsville, Queensland, Australia
  • Adelaide Oncology and Haematology North Adelaide, South Australia, Australia
View Trial Details

Related conditions